The High Cost of Slow: What Every Missed Signal Costs Launch & Growth Brands

In today’s high-velocity pharmaceutical market, even the most innovative therapies often fall short when launch execution lags. A few weeks of stalled decisions can equate to millions or even billions in lost revenue – and teams rarely recover once first-year momentum is gone.

In our eBook, The High Cost of Slow: What Every Missed Signal Costs Launch & Growth Brands, we explore real-world examples to show how missteps can compound over time and lead to poor launch performance despite having a blockbuster potential asset in hand. In addition, the piece also provides a framework for how launch teams can build the agility needed to maximize market performance.

Fill out the form to download the eBook.